"10.1371_journal.pone.0059692","plos one","2013-03-20T00:00:00Z","Elisabet S√°nchez; Rub√©n Franc√©s; Germ√°n Soriano; Beatriz Mirelis; Francesc J Sancho; Jos√© Manuel Gonz√°lez-Navajas; Carlos Mu√±oz; Xiao-yu Song; Miguel P√©rez-Mateo; Jos√© Such; Carlos Guarner","Liver Section, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigaci√≥n Biom√©dica en Red en el √Årea tem√°tica de Enfermedades Hep√°ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; Institut dInvestigacions Biom√©diques de Sant Pau (IIB), Barcelona, Spain; Universitat Aut√≤noma de Barcelona, Bellaterra (Cerdanyola del Vall√®s), Spain; Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Unidad Hep√°tica, Hospital General Universitario, Universidad Miguel Hern√°ndez, Alicante, Spain; Department of Microbiology, Hospital General Universitario, Universidad Miguel Hern√°ndez, Alicante, Spain; Research and Development Centocor, Malvern, Pennsylvania, United States of America","Conceived and designed the experiments: CG JS. Performed the experiments: ES RF FJS. Analyzed the data: ES RF GS BM FJS JS CG. Contributed reagents/materials/analysis tools: ES RF GS BM FJS JMG CM XYS MPM JS CG. Wrote the paper: ES CG JS RF.","Centocor (Malvern, PA, USA) provided funding to conduct this investigation, and is the employer of XYS. The anti-TNF mAb used in this study is a product of Centocor. There are no further patents, products in development or marketed products to declare. This does not alter the authors‚Äô adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","03","Elisabet S√°nchez","ES√",11,TRUE,2,3,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
